SYNG PHARMACEUTICALS
SYNG Pharma is a biotechnology company focused on developing diagnostic and therapeutic for endometriosis.
SYNG PHARMACEUTICALS
Industry:
Biometrics Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
Kingston, Ontario, Canada
Country:
Canada
Website Url:
http://www.syngpharma.com
Total Employee:
1+
Status:
Active
Contact:
613-532-9426
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Content Delivery Network LetsEncrypt SSL By Default HSTS Organization Schema Sitelinks Search Box Person Schema
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
GoDx
GoDx is a biotechnology research center, developing a simple diagnostic test for the detection of infectious pathogens.
Immunotrex Biologics
Immunotrex Biologics is a biotechnology company focusing on novel molecular diagnostic devices as well as therapeutic strategies.
NanoLight Technologies
NanoLight Technologies is a biotechnology company developing broad applications of natural and light-emitting marine proteins.
Current Employees Featured
Founder
Official Site Inspections
http://www.syngpharma.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "SYNG Pharmaceuticals"
Team - SYNG Pharmaceuticals
Emerging Biotech Team Developing Endometriosis Test and Non-hormonal TherapySee details»
SYNG Pharmaceuticals Inc - LinkedIn
SYNG Pharmaceuticals Inc. (SYNG Pharma) is a pre-clinical stage biotechnology company dedicated to developing next generation diagnostic and therapeutic against endometriosis.See details»
SYNG Pharmaceuticals - PitchBook
Www.syngpharma.com. Ownership Status. Privately Held (no backing) Financing Status. Corporation. Corporate Office. ... Ontario Bioscience Innovation Organization: Not-For-Profit …See details»
Riipen | SYNG Pharmaceuticals Inc
Description Endometriosis affects an estimated 200 million women worldwide that are unduly suffering; facing debilitating pain each day, abnormal bleeding and infertility.See details»
SYNG Pharmaceuticals - Crunchbase Company Profile & Funding
SYNG Pharma is a biotechnology company focused on developing diagnostic and therapeutic for endometriosis.See details»
SYNG Pharmaceuticals Inc - VentureRadar
Website: https://www.syngpharma.com. Develops innovative diagnostic and therapeutic solutions for endometriosis and castration-resistant prostate cancer through cutting-edge biotechnology …See details»
Contact - SYNG Pharmaceuticals
Emerging Biotech Developing Endometriosis Test and Non-hormonal TherapySee details»
Syng Pharmaceuticals - Overview, News & Similar companies
Oct 8, 2022 Syng Pharmaceuticals contact info: Phone number: (613) 532-9426 Website: www.syngpharma.com What does Syng Pharmaceuticals do? SYNG Pharmaceuticals Inc. …See details»
SYNG Pharmaceuticals Inc. - CMOCRO
SYNG Pharmaceuticals Inc. is a pre-clinical stage biotechnology company dedicated to developing next generation diagnostic and therapeutic against endometriosis.See details»
SYNG Pharmaceuticals - Craft
SYNG Pharmaceuticals (SYNG Pharma) is a biotech company that provides blood tests and non-hormonal therapy for endometriosis. It develops SP011, a peptide to inhibit a target engaged …See details»
SYNG Pharma | Smith Magazine
My company, SYNG Pharmaceuticals Inc. (SYNG Pharma), is an early-stage venture incubated in Johnson & Johnson Innovation’s [email protected] research discoveries originating at …See details»
SYNG Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 945 Princess Street . Kingston, Ontario, K7L 3N6, Canada. 613-532-9426See details»
SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent …
SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian...See details»
Technology | SYNG Pharmaceuticals
The recent marketing launch of Elagolix®, oral hormone therapy for endometriosis, has re-invigorated the conversation and drawn the attention of global community towards an unmet …See details»
SYNG Pharmaceuticals CEO, Founder, Key Executive Team, Board …
Explore {SYNG Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
SYNG Pharmaceuticals Inc on LinkedIn: Why We Need to Talk …
Endometriosis is a prevalent yet often misunderstood and overlooked condition that affects millions of women worldwide. Despite its significant impact on women's lives, endometriosis …See details»
EndoID | SYNG Pharmaceuticals
SyngPharma recherche actuellement des personnes pour participer à une étude de recherche visant à développer notre test sanguin, EndoID. Si vous souhaitez faire progresser les soins …See details»
SYNG Pharmaceuticals Inc - Facebook
SYNG Pharmaceuticals Inc. 160 likes. SYNG Pharmaceuticals Inc (SYNG Pharma) is a biotechnology company developing a first in class diagnoSee details»
News - SYNG Pharmaceuticals
SYNG Pharmaceuticals Inc. (SYNG), a Kingston-based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada …See details»